Despite favorable reviews of CE in comparison with gel-based protein electrophoresis (3, 4 ) , both false-positive and false-negative results have been reported. Because CE measures absorbance at 214 nm, substances other than proteins have been reported to produce suspicious bands. Radio-contrast media that absorb at this wavelength produce discrete bands that may be mistaken for Mproteins (7 ) . Fortunately, this may be removed by desalting (8 ) . Difficulties in detecting M-proteins in serum from six patients by CE were reported by Jenkins and Guerin (9 ) . They noted difficulty in separating five IgM M-proteins that had slow ␥-region migration. A modification in the boric acid buffer system and pH allowed detection of these M-proteins.
In the present case, the M-protein was detected, but at a much lower concentration than indicated by nephelometry or high-resolution agarose gels. Treatment with 2-ME produced an M-protein peak that was more consistent with the other results. With immunoelectrophoresis, 2-ME treatment improved identification of IgM M-proteins because IgM monomers migrate more readily through the agarose than the IgM pentamer. The characteristics of this IgM M-protein that may have interfered with its passage through the capillary or that imparted an affinity for the capillary wall are not known. However, the 2-ME treatment was able to ameliorate this and effect a more reasonable measurement of the M-protein.
We recommend that laboratories using CE consider the use of 2-ME to evaluate M-proteins when the nephelometric concentrations or clinical features are inconsistent with the CE electropherogram measurement. 
Influence Quantities and Uncertainty of Measurement
To the Editor: According to the International Organization for Standardization (ISO), an "influence quantity" is a "quantity that is not the measurand but that affects the result of the measurement" [the measurand being the particular quantity subject to measurement] (1 ). The effect of an influence quantity on the measurement process is an interference that generates a systematic error. In clinical chemistry, depending on the molecular entity responsible for an interference, influence quantities may be classified as endogenous or exogenous.
Concentrations of bilirubin, hemoglobin, and triglyceride in plasma (or serum) are generally studied by the in vitro diagnostic industry in the development of measurement systems as potential endogenous influence quantities. However, depending on the criteria that the reagent manufacturer uses to decide whether the systematic error caused by an influence quantity is significant, influence quantities may be the most important component of the uncertainty of a patient's result. Let me illustrate this statement using the measurement of urate substance concentration in plasma as an example.
In this example, the substance concentration (subst. c.) of urate [uric acid and urate ion in equilibrium (2 )] in plasma (P) is measured using a procedure based on an uricase/peroxidase method. According to the ISO, the numeric part of this result is incomplete because a complete statement of a measurement result must include information about the dispersion of the values that could reasonably be attributed to the measurand (i.e., the uncertainty of measurement) (1, 4 ) . This information usually is given as a standard deviation or the half-width of an interval having a stated level of confidence.
To estimate the uncertainty of measurement in our example, we assume that the sources of uncertainty are only premetrological variability, uncertainty of the calibrator assigned value, day-to-day imprecision, and endogenous influence quantities.
Premetrological variability. For blood quantities, the premetrological phase
Clinical Chemistry 47, No. 7, 2001 (preexamination or preanalytical phase, when a broader sense is necessary) begins when the needle is first inserted into the vein and lasts until the sample enters the measurement system. The CV observed in this phase for the quantity measured is 0.8% (5 ) , which in our example corresponds to a standard deviation, or standard uncertainty, of 2.2 mol/L.
Uncertainty of the value assigned to the calibrator. The manufacturer of the calibrator does not declare the uncertainty of the assigned value. Because the uncertainty of the assigned value of the reference material SRM 909b, to which the calibrator is traceable, expressed as relative standard deviation is 1%, we can (optimistically) assume the same uncertainty for the calibrator. Thus, because the assigned value of calibrator is 301 mol/L, the standard uncertainty attributable to the calibrator is 3.0 mol/L.
Day-to-day imprecision.
The measurement procedure of this example has an heteroscedastic behavior with a day-to-day CV within the measurement range equal to 1.1%. This imprecision applied to the patient's result (275 mol/L) expressed as standard deviation, or standard uncertainty, is 3.0 mol/L.
Endogenous influence quantities.
The criterion of the manufacturer of the reagent for deciding whether a potential influence quantity should be declared as an interference is that the relative systematic error produced by the influence quantity must be more than Ϯ 10%. In spite of this criterion being presented as a symmetric interval (Ϯ 10%), the changes of the value of the measurand that may provoke a particular influence quantity will be within the interval (0%; 10%) or (Ϫ10%; 0%). Because it is more likely that an endogenous interference will not be present than the opposite, the effect of a possible influence quantity probably will be closer to 0% than to 10% or Ϫ10%. In these cases, the systematic errors that may produce an influence quantity follow a triangular (right-angle trian-gle) distribution (6, 7 ) and the standard uncertainty (u) is:
where a and b are, respectively, the lower and upper limits of the interval. Applying the above equation to our example:
This percentage applied to the patient's result (275 mol/L) corresponds to 6.6 mol/L, but because there are three influence quantities studied by the reagent manufacturer, the estimated standard uncertainty should be multiplied by 3:
When the standard uncertainties of every uncertainty component have been estimated, the combined standard uncertainty (u c ) attributable to all of these components may be estimated (4, 8 ) :
Finally, we will estimate the expanded uncertainty (U) with a confidence level 1 Ϫ ␣ Ϸ 0.95, multiplying the combined standard uncertainty by a coverage factor (k) equal to 2 (4, 8 ) :
U ϭ u c ϫ k ϭ 12.4 ϫ 2 ϭ 24.8 mol/L Thus, the complete patient's result, after rounding the value of the expanded uncertainty as is usually done for the measurement result, will be:
Keeping all of the above in mind, it seems clear that more effort should be devoted to improve the metrological specificity of the measurement procedures used in clinical laboratory sciences, because in many cases, influence quantities, in spite of being not significant, may be, quantitatively, the more important component of the uncertainty of a patient's result.
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Serendipitous Detection of Umbilical Venous Catheter Displacement by Cardiac Troponin I Measurement
To the Editor:
The measurement of cardiac troponin I (cTnI) is pivotal in the biochemical diagnosis of myocardial damage in adults and in infants as well (1 ) . cTnI could also be used in other pathologies that may affect the neonatal heart, such as birth asphyxia, primary pulmonary hypertension, sepsis, and multiple organ system failure (2, 3 ) . A newly born term male suffered a
